Skip to main content

Diabetes & Weight Loss News

Twitter summary: AACE/ACE publish position statement on obesity w/ 4 step plan: screen, examine, evaluate, treat/prevent! Kudos 4 focus on proactive diagnosis The...
Twitter summary: @omadahealth announces $950K in funding to bring #diabetes prevention program to low-income communities On September 17, Omada Health announced that it...
A controversial and groundbreaking ballot vote next month – how the Bay Area hopes to tackle diabetes and obesity.
Twitter summary: After huge anticipation for this innovative drug combination, Novo Nordisk’s Xultophy received approval in Europe for #T2D, 1 st ever basal insulin/GLP-...
Twitter summary: CDC releases state-by-state obesity data, several states see increases in adult obesity rates – childhood obesity rates level off The Center for Disease...
Twitter summary: FDA approves Contrave weight management drug, with potential future use in #T2D On September 10, the FDA announced the approval of Orexigen’s weight...
Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...
The provocative documentary Fed Up , which offers an unflinching look at the real causes and challenges of America’s obesity epidemic, is currently playing in select...
How are the bacteria in our gut related to type 2 diabetes and obesity? The fascinating research.
What do Michelle Obama, soda, and cities have in common? Our top five patient takeaways from PHA this year.
On December 11, Orexigen announced the resubmission of its weight management drug Contrave (naltrexone/bupropion) to the FDA. The company has previously stated that it...
James Hirsch assesses the implications for diabetes from the bestseller Salt Sugar Fat .
Kelly on the shocking new data just released on diabetes costs and what we can do about it.
What really causes weight gain? A fascinating review in the New England Journal of Medicine details myths and facts about obesity.
The giant Consumer Electronics Show, held each January in Las Vegas, had a variety of devices relevant to diabetes and obesity this year. Media buzz surrounded the...
The Journal of the American Medical Association (JAMA) published a controversial meta-analysis suggesting that people who are overweight (a body mass index [BMI] of 25-...
The New England Journal of Medicine just published the results of a poll (1,290 votes from 75 countries) that asked readers to vote on the government regulation (e.g.,...
This month, in a surprise move, Vivus announced that its weight management medication Qsymia is now available via mail order through Walmart. This is an addition to the...
In late November, Vivus launched its Get Started! Program , which gives potential users of its weight management medication Qsymia a chance to try the drug free for two...
The past few months have seen the approval of a pair of new drugs designed to treat obesity, Arena’s Belviq (see new now next in diaTribe #44) and Vivus’ Qsymia (see new...

Pages